On April 6, 2011, Michael W. Weiner, MD, Director of the SFVAMC Center
for Imaging of Neurodegenerative Diseases and Principal Investigator of the
Alzheimer's Disease Neuroimaging Initiative (ADNI), accepted the Ronald and
Nancy Reagan Research Award from the Alzheimer's Association. The Association presented
the award to ADNI "for its collaborative and innovative approaches to
furthering Alzheimer treatment, prevention and care," citing Dr. Weiner for his
"extraordinary leadership [which] has helped make ADNI the largest
public-private Alzheimer's disease research partnership in our country."
ADNI is a $140,000,000 multi-year clinical trial involving more than
one thousand patients at 55 centers in the United States and Canada. Its
purpose is to establish biomarkers for the progression of Alzheimer's disease
based on markers in the brain, spinal fluid, and blood. Much of the project's
funding is administered by NCIRE-The Veterans Health Research Institute.
am incredibly moved by this," said Dr. Weiner, who is also a Professor of
Radiology, Medicine, Psychiatry, and Neurology at the University of California,
San Francisco. "Of course, none of this would be possible without the huge
support that our research group and I have received during the past decades
from the leadership of the VA, NCIRE, and UCSF."